SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (311)1/15/2002 11:00:52 AM
From: JFitnich  Read Replies (1) | Respond to of 1022
 
Thanks for compiling the presentation for the rest of us.

I own MEDX & ABGX. I only wish the patent situation was better defined in this category (phage display). I need to do a lot more work before I feel comfortable investing here. The emerging pipeline (and D2E7) has me looking at CATG.

Jason



To: nigel bates who wrote (311)1/15/2002 1:08:39 PM
From: jayhawk969  Read Replies (1) | Respond to of 1022
 
Nigel,

I am showing a market cap of aprox $890 MM. This is about 35% of ABGX and 80% of MEDX. ABGX has substantially more cash. I wonder how much of the valuation difference is due to CATG being a UK company?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News